| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -2,005 | -3,082 | 709 | -50,331 |
| Depreciation and amortization | 41,319 | 27,762 | 13,756 | 56,279 |
| Non-cash operating lease costs | 31,265 | 20,669 | 10,231 | 29,431 |
| Stock-based compensation | 57,997 | 39,700 | 18,584 | 60,026 |
| Amortization of discount and debt issue costs | 762 | 506 | 251 | 1,264 |
| Gain on remeasurement of contingent consideration | 0 | 0 | 0 | 1,975 |
| Other, net | -1,440 | -753 | -357 | -998 |
| Patient accounts receivable, net | -10,729 | -2,318 | 8,568 | 32,757 |
| Prepaid expenses and other current assets | 10,410 | 15,179 | 4,515 | 3,924 |
| Accounts payable | 2,868 | -277 | -77 | 620 |
| Accrued payroll expenses | -3,689 | 11,725 | -17,540 | 9,381 |
| Operating lease liabilities | -35,829 | -23,498 | -11,894 | -34,300 |
| Other accrued expenses | -5,856 | -93 | -4,386 | 10,232 |
| Net cash provided by operating activities | 88,591 | 61,304 | -3,092 | 44,944 |
| Purchases of property and equipment | 25,214 | 14,923 | 7,168 | 15,265 |
| Acquisitions of businesses, net of cash acquired | - | - | - | 0 |
| Net cash used in investing activities | -25,214 | -14,923 | -7,168 | -15,265 |
| Proceeds from long-term debt | - | - | - | 0 |
| Payments of debt issue costs | - | - | - | 0 |
| Payments of long-term debt | 5,438 | 3,625 | 1,813 | 2,194 |
| Payments of contingent consideration | 0 | 0 | 0 | 3,694 |
| Taxes related to net share settlement of equity awards | 8,607 | 8,398 | 8,162 | - |
| Net cash used in financing activities | -14,045 | -12,023 | -9,975 | -5,888 |
| Net increase in cash and cash equivalents | 49,332 | 34,358 | -20,235 | 23,791 |
| Cash and cash equivalents at beginning of period | 154,571 | 154,571 | 154,571 | 78,824 |
| Cash and cash equivalents at end of period | 203,903 | 188,929 | 134,336 | 102,615 |
LifeStance Health Group, Inc. (LFST)
LifeStance Health Group, Inc. (LFST)